In (A), under COSMIC tissue selection large Intestine is selected, thence colon subtissue and carcinoma histology and adenocarcinoma subhistology. In (B), under COSMIC tissue selection central nervous system is selected, thence brain subtissue and glioma histology and select ‘all’ for subhistology. In (C), under COSMIC tissue selection select lung, thence ‘all’ subtissue, thence under histology carcinoma is selected thence, ‘all’ for subhistology. In (D), under COSMIC tissue selection select lung, thence ‘all’ subtissue thence carcinoma for histology thence under subhistology select adenocarcinoma. In (E), under COSMIC tissue selection select skin, thence ‘all’ subtissue sites thence malignant melanoma histology thence ‘all’ subhistologies. In (F), under COSMIC tissue selection also select skin, thence ‘all’ subtissue sites and thence under histology select carcinoma, thence under subhistology select basal cell carcinoma. In (G), under COSMIC tissue selection also select skin, thence ‘all’ subtissue sites and thence under histology select carcinoma, thence under subhistology select squamous cell carcinoma. In (H), under COSMIC tissue selection select liver and under subtissue sites select ‘all’, thence under histology select carcinoma and thence under subhistology select hepatocellular carcinoma. In (I), under COSMIC tissue selection select breast thence subtissue select ‘all’, thence under histology select carcinoma thence under subhistology select ‘all’. In (J), under COSMIC tissue select salivary gland and ‘all’ as subtissue and thence carcinoma as histology thence ‘all’ as subhistology. In (K), under COSMIC tissue select upper aerodigestive tract thence mouth as subtissue, thence carcinoma as histology thence under subhistology select squamous cell carcinoma. In (L), under COSMIC tissue select pancreas thence subtissue select ‘all’, thence under histology select carcinoma, thence ‘all’ subhistologies. In (M), under COSMIC tissue select haematopoietic and lymphoid tissue thence ‘all’ under subtissue selection thence haematopoietic neoplasm under histology selection thence under subhistology select acute myeloid leukaemia (AML), chronic myeloid leukaemia (CML) or myelodysplastic syndrome. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Table 1: COSMIC (Catalogue of Somatic Mutations in Cancer) analysis showing the frequency of substitution nonsense (SN) mutations from a range of cancers. The selected TS (Tumour Suppressors) are those presenting with mutations that are within the category of the most frequently altered genes for each indicated cancer. Designations (for example, subtissue and subhistology) are as annotated on COSMIC. Total mutations represent deletions/frameshift/insertions/missense/substitution nonsense in toto for the indicated TS gene for the particular cancer/histology type as per COSMIC. The percentage of the total alterations for the indicated TS and histologytype that are SN is presented in the last column. COSMIC data extracted July, 2013. |